Addex Therapeutics Ltd ADR (ADXN)

$8.84 +0.45 (5.36%)
Market Cap 8.88M
Revenue (ttm) 460,000.00
Net Income (ttm) 8.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,741.30%
Debt to Equity Ratio 0.00
Volume 1,390
Avg Vol 6,210
Day's Range N/A - N/A
Shares Out 1.06M
Stochastic %K 9%
Beta 1.62
Analysts Strong Buy
Price Target $30.00

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (m...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 22 884 1555
Fax: 41 22 884 1556
Address:
Chemin des Mines, 9, Geneva, Switzerland
L2Lurker
L2Lurker Jun. 12 at 8:06 PM
$ADXN 👀
0 · Reply
PenkeTrading
PenkeTrading Jun. 7 at 5:45 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Addex Therapeutics Ltd. Is that bullish or bearish? $ADXN #Addex #RsiOverbought #NASDAQ
0 · Reply
topstockalerts
topstockalerts Jun. 6 at 8:06 PM
$ADXN Strong action today..👀👀👀
0 · Reply
flybyme
flybyme Jun. 6 at 7:42 PM
$ADXN good to see this board coming a live, maybe like old times, if it keeps climbing
0 · Reply
waterfall223
waterfall223 Jun. 6 at 7:19 PM
$ADXN interesting 🤨
0 · Reply
The_Titan_Traders
The_Titan_Traders Jun. 6 at 7:05 PM
$ADXN $JNJ $LLY $QQQ $SPY ADXN starting to get noticed
0 · Reply
The_Titan_Traders
The_Titan_Traders Jun. 6 at 6:43 PM
$ADXN how did this news this morning go unseen? When big boards find this one it should go insaneeeeee. $SPY $QQQ $LLY $JNJ https://x.com/tt_stocks_/status/1931058089199026513?s=46
0 · Reply
Jnuckle
Jnuckle Jun. 6 at 6:16 PM
$ADXN
0 · Reply
waterfall223
waterfall223 Jun. 6 at 6:15 PM
$ADXN 🤔🤔
0 · Reply
Jnuckle
Jnuckle Jun. 6 at 6:03 PM
$ADXN
0 · Reply
Latest News on ADXN
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Jun 18, 2025, 1:00 AM EDT - 15 hours ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Jun 6, 2025, 1:00 AM EDT - 12 days ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Addex Convenes Annual General Meeting 2025

Jun 3, 2025, 1:00 AM EDT - 15 days ago

Addex Convenes Annual General Meeting 2025

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

May 12, 2025, 1:00 AM EDT - 5 weeks ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Apr 30, 2025, 1:00 AM EDT - 7 weeks ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Apr 25, 2025, 4:40 PM EDT - 7 weeks ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Apr 25, 2025, 1:00 AM EDT - 7 weeks ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Apr 17, 2025, 1:00 AM EDT - 2 months ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Addex to Present at the 2025 Swiss Equities Baader Conference

Jan 8, 2025, 1:00 AM EST - 5 months ago

Addex to Present at the 2025 Swiss Equities Baader Conference

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Nov 22, 2024, 11:11 AM EST - 7 months ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 22, 2024, 1:00 AM EST - 7 months ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Nov 11, 2024, 1:00 AM EST - 7 months ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Sep 30, 2024, 12:04 PM EDT - 9 months ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 30, 2024, 1:00 AM EDT - 9 months ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 19, 2024, 1:00 AM EDT - 9 months ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 1:00 AM EDT - 10 months ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Aug 27, 2024, 12:03 PM EDT - 10 months ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 10:47 AM EDT - 10 months ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Aug 27, 2024, 1:00 AM EDT - 10 months ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 22, 2024, 1:00 AM EDT - 11 months ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Addex Shareholders Approve All Resolutions at Annual General Meeting

Jul 1, 2024, 1:00 AM EDT - 1 year ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Jun 6, 2024, 12:50 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 6, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Addex Convenes Annual General Meeting 2024

Jun 5, 2024, 1:00 AM EDT - 1 year ago

Addex Convenes Annual General Meeting 2024

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 31, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Addex to Present at Bio€quity Europe 2024

May 8, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at Bio€quity Europe 2024

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 29, 2024, 1:00 AM EDT - 1 year ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Addex to Present at the Swiss Biotech Day 2024

Apr 19, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at the Swiss Biotech Day 2024

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Apr 18, 2024, 1:46 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 18, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 11, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Apr 3, 2024, 1:00 AM EDT - 1 year ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Addex to Present at the Bio-Europe Spring 2024 Conference

Mar 14, 2024, 2:00 AM EDT - 1 year ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 31, 2024, 1:00 AM EST - 1 year ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Addex to Present at the Swiss Equities Baader Conference

Jan 9, 2024, 1:00 AM EST - 1 year ago

Addex to Present at the Swiss Equities Baader Conference

Addex to Present at Biotech Showcase™ 2024

Jan 5, 2024, 1:30 AM EST - 1 year ago

Addex to Present at Biotech Showcase™ 2024

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Dec 20, 2023, 1:00 AM EST - 1 year ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Addex Creates Treasury Shares

Dec 14, 2023, 1:00 AM EST - 1 year ago

Addex Creates Treasury Shares

Addex Therapeutics Ltd (ADXN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 1:41 PM EST - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2023 Earnings Call Transcript

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Nov 29, 2023, 1:00 AM EST - 1 year ago

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Addex Convenes Extraordinary General Meeting

Nov 28, 2023, 1:00 AM EST - 1 year ago

Addex Convenes Extraordinary General Meeting

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

Nov 23, 2023, 1:00 AM EST - 1 year ago

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients

Nov 14, 2023, 1:00 AM EST - 1 year ago

Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients

Addex Regains Nasdaq Listing Compliance

Nov 8, 2023, 1:00 AM EST - 1 year ago

Addex Regains Nasdaq Listing Compliance

Addex Announces Participation in the Bio-Europe 2023 Conference

Nov 2, 2023, 2:00 AM EDT - 1 year ago

Addex Announces Participation in the Bio-Europe 2023 Conference

Addex Completes ADS Ratio Change

Oct 20, 2023, 1:00 AM EDT - 1 year ago

Addex Completes ADS Ratio Change

Addex Announces Plan to Implement ADS Ratio Change

Oct 6, 2023, 4:00 PM EDT - 1 year ago

Addex Announces Plan to Implement ADS Ratio Change

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant

Sep 20, 2023, 1:00 AM EDT - 1 year ago

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant

L2Lurker
L2Lurker Jun. 12 at 8:06 PM
$ADXN 👀
0 · Reply
PenkeTrading
PenkeTrading Jun. 7 at 5:45 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Addex Therapeutics Ltd. Is that bullish or bearish? $ADXN #Addex #RsiOverbought #NASDAQ
0 · Reply
topstockalerts
topstockalerts Jun. 6 at 8:06 PM
$ADXN Strong action today..👀👀👀
0 · Reply
flybyme
flybyme Jun. 6 at 7:42 PM
$ADXN good to see this board coming a live, maybe like old times, if it keeps climbing
0 · Reply
waterfall223
waterfall223 Jun. 6 at 7:19 PM
$ADXN interesting 🤨
0 · Reply
The_Titan_Traders
The_Titan_Traders Jun. 6 at 7:05 PM
$ADXN $JNJ $LLY $QQQ $SPY ADXN starting to get noticed
0 · Reply
The_Titan_Traders
The_Titan_Traders Jun. 6 at 6:43 PM
$ADXN how did this news this morning go unseen? When big boards find this one it should go insaneeeeee. $SPY $QQQ $LLY $JNJ https://x.com/tt_stocks_/status/1931058089199026513?s=46
0 · Reply
Jnuckle
Jnuckle Jun. 6 at 6:16 PM
$ADXN
0 · Reply
waterfall223
waterfall223 Jun. 6 at 6:15 PM
$ADXN 🤔🤔
0 · Reply
Jnuckle
Jnuckle Jun. 6 at 6:03 PM
$ADXN
0 · Reply
Weel
Weel Jun. 6 at 6:01 PM
$ADXN
0 · Reply
The_Titan_Traders
The_Titan_Traders Jun. 6 at 5:54 PM
Initiating a position in $ADXN, this DD looks amazing! https://x.com/heartratetrader/status/1931035922180755595?s=46
0 · Reply
VieInoui
VieInoui Jun. 6 at 5:41 PM
$ADXN
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 6 at 10:59 AM
WATCHLIST JUN 06 2025 $KITT Nauticus Robotics Announces Strategic Collaboration With Open Ocean Robotics To Combine Autonomous Subsea Vehicles And Solar-Powered USVs $ADXN Addex Therapeutics Reports Preclinical Results For GABAB PAM, Demonstrating Superior Efficacy And Tolerability In Chronic Cough Models $AMTX Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $20 $ELBM Electra Battery Materials Announced Thursday Completion Of A Feasibility Level Class 3 Engineering Study For Construction Of A Modular Battery Recycling Facility Adjacent To Its Cobalt Sulfate Refinery North Of Toronto $CIGI Colliers Announces Englobe's Acquisition Of Ontario-Based Cambium Inc. To Expand Engineering Capabilities And Market Presence in Canada; No Financial Terms Disclosed
0 · Reply
DonCorleone77
DonCorleone77 Jun. 6 at 10:47 AM
$ADXN Addex reports anti-tussive activity of GABAB positive allosteric modulator Addex Therapeutics announced robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor positive allosteric modulator in multiple preclinical models of chronic cough compared to reference drugs. Some of these preclinical data with Addex GABAB PAM drug candidate will be presented on June 7 at the 10th American Cough Conference, in Dulles, Virginia by Mikhail Kalinichev, head of translational science at Addex. In models of chronic cough, the GABAB PAM drug candidate significantly reduced citric acid-induced cough frequency, increased cough latency and showed no signs of tolerance after sub-chronic treatment. In the same model, the antitussive efficacy of the Addex GABAB PAM drug candidate appears to be superior to that observed with nalbuphine, baclofen, codeine or a P2X3 inhibitor. In addition, the tolerability of the GABAB PAM candidate demonstrated better tolerability and a wider therapeutic margin than that observed with nalbuphine, baclofen, or codeine, while being similar to that of a P2X3 inhibitor, based on the compound's activity on respiratory rate.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 5 at 10:53 AM
WATCHLIST JUN 05 2025 $BWXT BWXT's KINECTRICS Expands Global High Voltage Cable Commissioning Services With Multi-Million-Dollar Investment In HIGHVOLT Technology $RNXT Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $11.5 $IPX IperionX On Wednesday Announced Award Of U.S. Department Of Defense SBIR Phase III Contract For Up To $99M $ADXN Addex Therapeutics To Present Preclinical Data On GABAB Positive Allosteric Modulator Showing Antitussive Effects In Guinea Pig Cough Models At 10th American Cough Conference $IMUX Immunic Announces Addl Data From Phase 2 CALLIPER Trial In Progressive MS, Supporting Recently Released Top-Line Results and Underlining Vidofludimus Calcium's Neuroprotective Potential
0 · Reply
flybyme
flybyme Jun. 2 at 7:07 PM
$ADXN any surprises tomorrow, proberly not.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 12 at 10:46 AM
WATCHLIST MAY 12 2025 $JOBY Joby Aviation Flies Two Air Taxis Together for First Time, Marking Major Leap Toward Commercial Launch $APGE Apogee Therapeutics Released Interim Data From Its Phase 1b Trial Of APG808, A Novel Half-life Extended IL-4Rα Antibody, In Patients With Mild-to-moderate Asthma $ADXN Addex Therapeutics Announces Milestone As Indivior Completes Preclinical Phase Of GABAB Positive Allosteric Modulator Program $FUFU HC Wainwright & Co. Reiterates Buy on BitFuFu, Maintains $7 Price Target $GRYP Gryphon Digital to Merge With Hut 8 Corp Subsidiary American Bitcoin, Forming New Nasdaq-Listed Crypto Powerhouse 'ABTC'
0 · Reply
flybyme
flybyme Apr. 25 at 3:31 PM
$ADXN Addex and partner Janssen Pharmaceuticals end cooperation OH WELL, years of the same.
0 · Reply
TomCain
TomCain Apr. 21 at 1:52 AM
$ADXN $WAL $CMA $TSLA $GE
0 · Reply
Aurum81
Aurum81 Apr. 17 at 1:54 PM
$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-regains-rights-phase-2-mglu2-pam-asset-adx71149/
0 · Reply
Lowlow1
Lowlow1 Apr. 1 at 3:21 PM
$ADXN AGMH very good price to jump in at 0.042 has to get to a dollar soon if I post again mybad ...,....
0 · Reply